Robert Cooper
Family Medicine · Williamsburg, KYNPI 1194729525
Payments from drug & device makers
Across 110 payments — averaging $17.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$328
- AbbVie$264
- Bayer$196
- Amgen$190
- Novo Nordisk$171
- GSK$157
- plus $605 from 13 others
What the payments were for
- Food & beverage$1,911100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 21 | $328 |
| AbbVie(2 entities) | 17 | $264 |
| Bayer | 11 | $196 |
| Amgen | 10 | $190 |
| Novo Nordisk | 12 | $171 |
| GSK | 9 | $157 |
| Abbott | 8 | $153 |
| Merck | 6 | $116 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $59 |
| Medtronic | 1 | $48 |
| Biohaven Pharmaceuticals, Inc. | 2 | $39 |
| Evoke Pharma, Inc. | 2 | $37 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Boehringer Ingelheim | 1 | $28 |
| Pfizer | 2 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Nestle Healthcare Nutrition Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $11 |
How this compares
$1,911 in reported general payments places this provider in the 65th percentile of 1,559 family medicine providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 69 | $51,648 |
| EliquisApixaban | 61 | $45,665 |
| OzempicSemaglutide | 17 | $19,625 |
| JardianceEmpagliflozin | 16 | $18,201 |
| VraylarCariprazine Hcl | 11 | $15,399 |
| RybelsusSemaglutide | 13 | $14,195 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 20 | $13,624 |
| LinzessLinaclotide | 22 | $12,585 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $11,033 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 38 | $8,370 |
| XareltoRivaroxaban | 14 | $7,714 |
| MyrbetriqMirabegron | 14 | $6,327 |
| Novolog FlexpenInsulin Aspart | 28 | $5,234 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 16 | $4,812 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 36 | $3,279 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere | $328 | $65,27389 claims |
| PfizerEliquis | $27 | $45,66561 claims |
| Novo NordiskOzempic, Rybelsus | $171 | $33,82030 claims |
| AbbVieVraylar, Linzess | $264 | $27,98433 claims |
| GSKTrelegy Ellipta, Shingrix, Arexvy | $157 | $24,21471 claims |
| Boehringer IngelheimJardiance | $28 | $18,20116 claims |
| Lilly USA, LLCHumalog | $15 | $2,43512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,559 family medicine providers in Kentucky.
Other family medicine in Williamsburg
- Brian SmithVersailles$7.7M
- Barbara Fleming-PhillipsLexington$1.4M
- Christopher RhyneLouisville$1M
- Kruti PatelBurlington$463K
- Michael LovelaceLouisville$244K
- John RichardLexington$226K
- Diego MastronardiBowling Green$196K
- James TurnboPaducah$124K
- Eleida Tur OlivaLexington$113K
- Jeffrey GreenParis$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.